(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Cardiovascular Abnormalities
This study will evaluate the nature and frequency of serious adverse events that occur up to 24 hours after completion of Definity medical imaging. The study is open to people 18 and older.
The research site is in New York City.
More information
Please see http://www.centerwatch.com/patient/studies/cat782.html.
-----
Gynecological Infections
Women 18 and older diagnosed with bacterial vaginosis or vulvovaginal candidiasis infections may be eligible for this study.
The research site is in San Diego, Calif.
More information
Please see http://www.centerwatch.com/patient/studies/cat296.html.
-----
Down Syndrome
This study will evaluate the use of donepezil hydrochloride (Aricept) in children with trisomy 21 down syndrome. Candidates aged 10 to 17 may qualify if they have mild-to-moderate cognitive dysfunction, reside in the community with a caregiver, have no unstable health conditions, are able to submit to blood tests, and are on stable doses of medication.
The research site is in St. Petersburg, Fla.
More information
Please see http://www.centerwatch.com/patient/studies/cat512.html.
-----
Copyright 2008 Thomson CenterWatch. All rights reserved.
2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.